CliniAtlasClinical evidence atlas / EUWriting from the CliniAtlas team in Split on clinical evidence, regulation, and the search tools European medicine deserves. Articles are currently published in English.
On a selected 200-case HealthBench Professional cohort, CliniAtlas recorded higher scores across five model backends and all three tested task categories, with overall gains of 9.26–25.30 points over archived direct-model baselines.
The Croatian Oncological Society has agreed a collaboration with CliniAtlas that gives every member of the Society free access to evidence search with linked sources.
The native CliniAtlas app brings cited evidence search, inspectable sources, and saved conversations to iPhone.
CliniAtlas can now take a second look at complex answers, work with images and PDFs, and turn a finished answer into a shareable report.
A bounded three-pass CliniAtlas workflow increased the mean length-adjusted score for all five models on a locked 100-case cohort drawn from HealthBench Hard.
OpenEvidence became unavailable in the EU and UK in April 2026. Here is what European clinicians should demand from any evidence-search replacement.
A guideline, regulatory assessment, randomized trial, and preprint answer different questions. CliniAtlas labels that context instead of flattening every reference into the same footnote.
Medical AI regulation starts with intended purpose and actual functionality. Here is how CliniAtlas defines its current evidence-review scope.
SmPC stands for Summary of Product Characteristics: the approved basis of information for European healthcare professionals on how to use a medicine safely and effectively. It should be easy to find beside the research literature.